Do analysts rate CNSP or JAGX?

CNS Pharmaceuticals presently has a consensus target price of $20.00, suggesting a potential upside of 378.01%. Given CNS Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe CNS Pharmaceuticals is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CNS Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate BDRX or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodexa Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, BDRX or JAGX?

Biodexa Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biodexa Pharmaceuticals N/A N/A -$8.42M N/A N/A Jaguar Animal Health $11.51M 0.16 -$53.43M -$591.92 N/A

Do analysts recommend JAGX or GNPX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Genprex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is JAGX or GNPX more profitable?

Genprex has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Genprex's return on equity of -247.32% beat Jaguar Animal Health's return on equity. Company Net Margins Return on Equity Return on Assets Jaguar Animal Health -169.04% -1,194.94% -115.55% Genprex N/A -247.32% -176.73%

Do analysts recommend JAGX or BCAB?

BioAtla has a consensus price target of $200.00, suggesting a potential upside of 5,212.08%. Given BioAtla's stronger consensus rating and higher possible upside, analysts clearly believe BioAtla is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioAtla 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate APVO or JAGX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptevo Therapeutics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Jaguar Animal Health (JAGX) Competitors

$3.00 +0.04 (+1.18%)

As of 10:26 AM Eastern

Compare

JAGX vs. CNSP, BDRX, GNPX, BCAB, and APVO

Should you buy Jaguar Animal Health stock or one of its competitors? MarketBeat compares Jaguar Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jaguar Animal Health include CNS Pharmaceuticals (CNSP), Biodexa Pharmaceuticals (BDRX), Genprex (GNPX), BioAtla (BCAB), and Aptevo Therapeutics (APVO). These companies are all part of the "pharmaceutical products" industry.

How does Jaguar Animal Health compare to CNS Pharmaceuticals?

CNS Pharmaceuticals (NASDAQ:CNSP) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends.

14.0% of CNS Pharmaceuticals shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 0.0% of CNS Pharmaceuticals shares are held by company insiders. Comparatively, 2.0% of Jaguar Animal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

CNS Pharmaceuticals presently has a consensus target price of $20.00, suggesting a potential upside of 378.01%. Given CNS Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe CNS Pharmaceuticals is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CNS Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

CNS Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. CNS Pharmaceuticals' return on equity of -238.68% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CNS Pharmaceuticals	N/A	-238.68%	-166.30%
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%

CNS Pharmaceuticals has a beta of 3.05, suggesting that its stock price is 205% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.09, suggesting that its stock price is 109% less volatile than the broader market.

In the previous week, CNS Pharmaceuticals and CNS Pharmaceuticals both had 1 articles in the media. CNS Pharmaceuticals' average media sentiment score of 1.89 beat Jaguar Animal Health's score of 0.94 indicating that CNS Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
CNS Pharmaceuticals	Very Positive
Jaguar Animal Health	Positive

CNS Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health. CNS Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CNS Pharmaceuticals	N/A	N/A	-$15.85M	-$29.63	N/A
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A

Summary

CNS Pharmaceuticals beats Jaguar Animal Health on 10 of the 14 factors compared between the two stocks.

How does Jaguar Animal Health compare to Biodexa Pharmaceuticals?

Biodexa Pharmaceuticals (NASDAQ:BDRX) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

Biodexa Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Biodexa Pharmaceuticals' return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodexa Pharmaceuticals	N/A	N/A	N/A
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodexa Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Biodexa Pharmaceuticals had 5 more articles in the media than Jaguar Animal Health. MarketBeat recorded 6 mentions for Biodexa Pharmaceuticals and 1 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.94 beat Biodexa Pharmaceuticals' score of 0.50 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Biodexa Pharmaceuticals	Neutral
Jaguar Animal Health	Positive

17.5% of Biodexa Pharmaceuticals shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 0.3% of Biodexa Pharmaceuticals shares are held by insiders. Comparatively, 2.0% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Biodexa Pharmaceuticals has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.09, suggesting that its stock price is 109% less volatile than the broader market.

Biodexa Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodexa Pharmaceuticals	N/A	N/A	-$8.42M	N/A	N/A
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A

Summary

Biodexa Pharmaceuticals beats Jaguar Animal Health on 7 of the 10 factors compared between the two stocks.

How does Jaguar Animal Health compare to Genprex?

Jaguar Animal Health (NASDAQ:JAGX) and Genprex (NASDAQ:GNPX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Genprex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 14.1% of Genprex shares are owned by institutional investors. 2.0% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 0.3% of Genprex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Jaguar Animal Health and Jaguar Animal Health both had 1 articles in the media. Genprex's average media sentiment score of 1.89 beat Jaguar Animal Health's score of 0.94 indicating that Genprex is being referred to more favorably in the news media.

Company	Overall Sentiment
Jaguar Animal Health	Positive
Genprex	Very Positive

Genprex has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Genprex's return on equity of -247.32% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%
Genprex	N/A	-247.32%	-176.73%

Genprex has lower revenue, but higher earnings than Jaguar Animal Health. Genprex is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A
Genprex	N/A	N/A	-$16.23M	-$14.14	N/A

Jaguar Animal Health has a beta of -0.09, indicating that its stock price is 109% less volatile than the broader market. Comparatively, Genprex has a beta of -0.98, indicating that its stock price is 198% less volatile than the broader market.

Summary

Genprex beats Jaguar Animal Health on 6 of the 11 factors compared between the two stocks.

How does Jaguar Animal Health compare to BioAtla?

Jaguar Animal Health (NASDAQ:JAGX) and BioAtla (NASDAQ:BCAB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Jaguar Animal Health has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market. Comparatively, BioAtla has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market.

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 77.2% of BioAtla shares are owned by institutional investors. 2.0% of Jaguar Animal Health shares are owned by insiders. Comparatively, 9.3% of BioAtla shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Jaguar Animal Health and Jaguar Animal Health both had 1 articles in the media. BioAtla's average media sentiment score of 1.87 beat Jaguar Animal Health's score of 0.94 indicating that BioAtla is being referred to more favorably in the news media.

Company	Overall Sentiment
Jaguar Animal Health	Positive
BioAtla	Very Positive

BioAtla has a consensus price target of $200.00, suggesting a potential upside of 5,212.08%. Given BioAtla's stronger consensus rating and higher possible upside, analysts clearly believe BioAtla is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioAtla	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

BioAtla has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. BioAtla's return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%
BioAtla	N/A	N/A	-325.64%

Jaguar Animal Health has higher revenue and earnings than BioAtla. BioAtla is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A
BioAtla	$2M	3.12	-$59.61M	-$41.72	N/A

Summary

BioAtla beats Jaguar Animal Health on 11 of the 15 factors compared between the two stocks.

How does Jaguar Animal Health compare to Aptevo Therapeutics?

Aptevo Therapeutics (NASDAQ:APVO) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

Aptevo Therapeutics has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Aptevo Therapeutics' return on equity of -198.50% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aptevo Therapeutics	N/A	-198.50%	-117.06%
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%

8.1% of Aptevo Therapeutics shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 0.1% of Aptevo Therapeutics shares are owned by insiders. Comparatively, 2.0% of Jaguar Animal Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aptevo Therapeutics	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Aptevo Therapeutics and Aptevo Therapeutics both had 1 articles in the media. Aptevo Therapeutics' average media sentiment score of 1.89 beat Jaguar Animal Health's score of 0.94 indicating that Aptevo Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Aptevo Therapeutics	Very Positive
Jaguar Animal Health	Positive

Aptevo Therapeutics has higher earnings, but lower revenue than Jaguar Animal Health. Aptevo Therapeutics is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aptevo Therapeutics	N/A	N/A	-$25.97M	-$197.60	N/A
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A

Aptevo Therapeutics has a beta of 1.68, suggesting that its stock price is 68% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.09, suggesting that its stock price is 109% less volatile than the broader market.

Summary

Aptevo Therapeutics beats Jaguar Animal Health on 8 of the 13 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAGX vs. The Competition

Export

Metric	Jaguar Animal Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.80M	$3.05B	$6.80B	$12.48B
Dividend Yield	N/A	1.87%	2.66%	6.22%
P/E Ratio	-0.01	19.69	25.72	24.65
Price / Sales	0.16	356.93	545.41	102.66
Price / Cash	N/A	56.85	29.09	36.93
Price / Book	-0.03	4.24	10.94	6.52
Net Income	-$53.43M	$64.45M	$3.57B	$336.61M
7 Day Performance	16.99%	2.81%	2.21%	1.24%
1 Month Performance	-15.63%	3.36%	0.55%	0.28%
1 Year Performance	-96.60%	34.26%	36.44%	30.62%

Jaguar Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAGX Jaguar Animal Health	0.3863 of 5 stars	$3.00 +1.2%	N/A	-96.6%	$1.80M	$11.51M	N/A	50	News Coverage
CNSP CNS Pharmaceuticals	3.9266 of 5 stars	$4.29 +0.2%	$20.00 +366.2%	-60.7%	$6.26M	N/A	N/A	5
BDRX Biodexa Pharmaceuticals	0.9097 of 5 stars	$2.78 -7.6%	N/A	-93.4%	$6.01M	$470K	N/A	20	News Coverage Analyst Revision
GNPX Genprex	0.8633 of 5 stars	$0.52 -5.3%	N/A	-95.4%	$6.01M	N/A	N/A	20	Positive News Gap Up
BCAB BioAtla	2.2 of 5 stars	$3.57 -1.4%	$200.00 +5,502.2%	-80.1%	$6M	$2M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JAGX) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jaguar Animal Health (JAGX) Competitors

JAGX vs. CNSP, BDRX, GNPX, BCAB, and APVO

How does Jaguar Animal Health compare to CNS Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Biodexa Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Genprex?

Summary

How does Jaguar Animal Health compare to BioAtla?

Summary

How does Jaguar Animal Health compare to Aptevo Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jaguar Animal Health (JAGX) Competitors

JAGX vs. CNSP, BDRX, GNPX, BCAB, and APVO

How does Jaguar Animal Health compare to CNS Pharmaceuticals?

Do institutionals and insiders have more ownership in CNSP or JAGX?

Do analysts rate CNSP or JAGX?

Is CNSP or JAGX more profitable?

Which has more risk and volatility, CNSP or JAGX?

Does the media refer more to CNSP or JAGX?

Which has better valuation and earnings, CNSP or JAGX?

Summary

How does Jaguar Animal Health compare to Biodexa Pharmaceuticals?

Is BDRX or JAGX more profitable?

Do analysts rate BDRX or JAGX?

Does the media refer more to BDRX or JAGX?

Do insiders and institutionals have more ownership in BDRX or JAGX?

Which has more risk & volatility, BDRX or JAGX?

Which has higher earnings & valuation, BDRX or JAGX?

Summary

How does Jaguar Animal Health compare to Genprex?

Do analysts recommend JAGX or GNPX?

Do insiders & institutionals believe in JAGX or GNPX?

Does the media favor JAGX or GNPX?

Is JAGX or GNPX more profitable?

Which has higher earnings & valuation, JAGX or GNPX?

Which has more risk and volatility, JAGX or GNPX?

Summary

How does Jaguar Animal Health compare to BioAtla?

Which has more volatility and risk, JAGX or BCAB?

Do insiders and institutionals have more ownership in JAGX or BCAB?

Does the media favor JAGX or BCAB?

Do analysts recommend JAGX or BCAB?

Is JAGX or BCAB more profitable?

Which has preferable earnings and valuation, JAGX or BCAB?

Summary

How does Jaguar Animal Health compare to Aptevo Therapeutics?

Is APVO or JAGX more profitable?

Do institutionals and insiders believe in APVO or JAGX?

Do analysts rate APVO or JAGX?

Does the media refer more to APVO or JAGX?

Which has preferable valuation & earnings, APVO or JAGX?

Which has more volatility and risk, APVO or JAGX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools